|
US8263402B1
(en)
*
|
1998-10-19 |
2012-09-11 |
Cornell Research Foundation, Inc. |
Method for isolating and purifying oligodendrocytes and oligodendrocyte progenitor cells
|
|
US6667176B1
(en)
|
2000-01-11 |
2003-12-23 |
Geron Corporation |
cDNA libraries reflecting gene expression during growth and differentiation of human pluripotent stem cells
|
|
US7410798B2
(en)
|
2001-01-10 |
2008-08-12 |
Geron Corporation |
Culture system for rapid expansion of human embryonic stem cells
|
|
US20050042749A1
(en)
|
2001-05-16 |
2005-02-24 |
Carpenter Melissa K. |
Dopaminergic neurons and proliferation-competent precursor cells for treating Parkinson's disease
|
|
GB2379447B
(en)
|
2000-05-17 |
2004-12-29 |
Geron Corp |
Neural progenitor cell populations
|
|
US7250294B2
(en)
|
2000-05-17 |
2007-07-31 |
Geron Corporation |
Screening small molecule drugs using neural cells differentiated from human embryonic stem cells
|
|
US6897061B1
(en)
*
|
2000-06-16 |
2005-05-24 |
Spinal Cord Society |
Transdifferentiation of glial cells
|
|
WO2003070171A2
(en)
|
2002-02-15 |
2003-08-28 |
Cornell Research Foundation, Inc. |
Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells
|
|
US7207743B2
(en)
*
|
2002-05-28 |
2007-04-24 |
Polivka Parking Solutions Llc |
Method and apparatus for constructing an automotive vehicle parking lot
|
|
US20050101014A1
(en)
|
2002-07-11 |
2005-05-12 |
Keirstead Hans S. |
Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
|
|
US7285415B2
(en)
|
2002-07-11 |
2007-10-23 |
The Regents Of The University Of California |
Oligodendrocytes derived from human embryonic stem cells for remyelination and treatment of spinal cord injury
|
|
AR046076A1
(es)
*
|
2003-07-18 |
2005-11-23 |
Otsuka Pharma Co Ltd |
Procedimiento para obtener una poblacion homogenea de celulas precursoras de oligodendrocitos y poblacion obtenida
|
|
EP1682075A4
(en)
*
|
2003-11-07 |
2009-12-09 |
Univ Florida |
CULTURE AND DIFFERENTIATION OF NEURONAL PRECURSOR CELLS
|
|
CA2560544C
(en)
|
2004-01-16 |
2015-05-19 |
Carnegie Mellon University |
Cellular labeling for nuclear magnetic resonance techniques
|
|
EP3000877B1
(en)
*
|
2004-06-09 |
2019-08-14 |
The University Court of the University of Edinburgh |
Neural stem cells
|
|
PL1838240T3
(pl)
*
|
2005-01-19 |
2018-09-28 |
Anika Therapeutics S.R.L. |
Pochodna kwasu hialuronowego i neuronalne komórki macierzyste do regeneracji SCI i PNT
|
|
US7803364B2
(en)
*
|
2005-11-17 |
2010-09-28 |
The Cleveland Clinic Foundation |
Multipotent neural stem cells
|
|
EP2012832A2
(en)
*
|
2006-04-14 |
2009-01-14 |
Celsense, Inc. |
Methods for assessing cell labeling
|
|
CA2649333C
(en)
*
|
2006-04-14 |
2016-10-04 |
Carnegie Mellon University |
Cellular labeling and quantification for nuclear magnetic resonance techniques
|
|
KR20090043559A
(ko)
|
2006-08-15 |
2009-05-06 |
에이전시 포 사이언스, 테크놀로지 앤드 리서치 |
중간엽 줄기세포 조절배지
|
|
EP2099869B1
(en)
|
2006-10-31 |
2013-05-01 |
Sensient Colors Inc. |
Modified pigments and methods for making and using the same
|
|
EP2136823A4
(en)
*
|
2007-04-17 |
2010-05-26 |
Univ Rochester |
TELECENTAL GLIAL RESTRICTED CELL POPULATIONS AND ASSOCIATED COMPOSITIONS AND METHOD
|
|
AU2008275578B2
(en)
*
|
2007-07-10 |
2014-04-10 |
Carnegie Mellon University |
Compositions and methods for producing cellular labels for nuclear magnetic resonance techniques
|
|
EP3483222A3
(en)
|
2007-08-23 |
2019-08-07 |
Sensient Colors LLC |
Self-dispersed pigments and methods for making and using the same
|
|
SG188096A1
(en)
|
2008-01-30 |
2013-03-28 |
Geron Corp |
Synthetic surfaces for culturing stem cell derived oligodendrocyte progenitor cells
|
|
WO2009116951A2
(en)
|
2008-03-17 |
2009-09-24 |
Agency For Science, Technology And Research |
Microcarriers for stem cell culture
|
|
AU2009241762B2
(en)
*
|
2008-05-02 |
2015-07-16 |
Celsense Inc. |
Compositions and methods for producing emulsions for nuclear magnetic resonance techniques and other applications
|
|
CA2723382A1
(en)
|
2008-05-08 |
2009-11-12 |
University Of Rochester |
Treating myelin diseases with optimized cell preparations
|
|
US9688956B2
(en)
|
2008-06-05 |
2017-06-27 |
National Cheng Kung University |
Method for preserving proliferation and differentiation potential of mesenchymal stem cells
|
|
WO2010008486A2
(en)
|
2008-06-24 |
2010-01-21 |
Parkinsons Institute |
Pluripotent cell lines and methods of use thereof
|
|
US20110236356A1
(en)
*
|
2008-12-12 |
2011-09-29 |
Nova Southeastern University |
Methods of isolating and using stem cells
|
|
EP3187581A1
(en)
|
2008-12-23 |
2017-07-05 |
BOCO Silicon Valley, Inc. |
Target populations of oligodendrocyte precursor cells and methods of making and using same
|
|
KR20110135989A
(ko)
|
2009-04-07 |
2011-12-20 |
센션트 컬러스 엘엘씨 |
자가-분산 입자 및 그의 제조 및 사용 방법
|
|
AU2010276201B2
(en)
|
2009-07-21 |
2013-10-17 |
Abt Holding Company |
Use of stem cells to reduce leukocyte extravasation
|
|
DK2456860T3
(en)
|
2009-07-21 |
2019-01-07 |
Abt Holding Co |
USE OF STEM CELLS FOR REDUCING LEUKOCYTE EXTRAVASATION
|
|
JP6002581B2
(ja)
*
|
2010-02-05 |
2016-10-05 |
オークランド ユニサービシズ リミテッドＡｕｃｋｌａｎｄ Ｕｎｉｓｅｒｖｉｃｅｓ Ｌｉｍｉｔｅｄ |
細胞プログラミング
|
|
AU2011220721B2
(en)
|
2010-02-25 |
2015-02-05 |
Abt Holding Company |
Modulation of macrophage activation
|
|
US9677042B2
(en)
|
2010-10-08 |
2017-06-13 |
Terumo Bct, Inc. |
Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
|
|
US8433419B2
(en)
|
2010-10-13 |
2013-04-30 |
Cardiac Pacemakers, Inc. |
Method and apparatus for controlling neurostimulation according to physical state
|
|
US20120308531A1
(en)
|
2011-06-06 |
2012-12-06 |
ReGenesys BVBA |
Expansion of Stem Cells in Hollow Fiber Bioreactors
|
|
EP2954046A4
(en)
|
2013-02-06 |
2016-07-20 |
Univ Rochester |
Oligodendrocyte precursor cells derived from isolated pluripotent cells to treat myelin disease
|
|
WO2014145653A2
(en)
|
2013-03-15 |
2014-09-18 |
Wake Forest University Health Sciences |
Neural progenitor cell differentiation
|
|
CN105338989B
(zh)
|
2013-04-12 |
2022-04-08 |
赛维里奥·拉弗朗切西卡 |
改进用于移植的器官
|
|
DK2992088T3
(da)
|
2013-04-30 |
2019-11-11 |
Univ Leuven Kath |
Celleterapi for myelodysplastiske syndromer
|
|
US9617506B2
(en)
|
2013-11-16 |
2017-04-11 |
Terumo Bct, Inc. |
Expanding cells in a bioreactor
|
|
US9724432B2
(en)
|
2015-04-30 |
2017-08-08 |
University Of Rochester |
Non-human mammal model of human degenerative disorder, uses thereof, and method of treating human degenerative disorder
|
|
US11406721B2
(en)
|
2016-02-22 |
2022-08-09 |
The Regents Of The University Of California |
Compositions and methods for imaging cell populations
|
|
EP3436567A4
(en)
|
2016-03-30 |
2019-10-30 |
Asterias Biotherapeutics, Inc. |
OLIGODENDROCYTE PROGENITOR CELL COMPOSITIONS
|
|
AU2018215170B2
(en)
*
|
2017-01-31 |
2021-11-11 |
Osaka University |
Differentiation control method for pluripotent stem cells
|
|
US11690876B2
(en)
|
2017-05-10 |
2023-07-04 |
University Of Rochester |
Methods of treating neuropsychiatric disorders
|
|
CN113474451A
(zh)
|
2019-01-23 |
2021-10-01 |
阿斯特里亚斯生物疗法股份有限公司 |
来自人多能干细胞的背源性少突胶质祖细胞
|
|
JP2022546317A
(ja)
|
2019-08-23 |
2022-11-04 |
サナ バイオテクノロジー，インコーポレイテッド |
Ｃｄ２４発現細胞およびそれらの用途
|
|
EP4125961A1
(en)
|
2020-03-25 |
2023-02-08 |
Sana Biotechnology, Inc. |
Hypoimmunogenic neural cells for the treatment of neurological disorders and conditions
|
|
AU2021325941A1
(en)
|
2020-08-13 |
2023-03-09 |
Sana Biotechnology, Inc. |
Methods of treating sensitized patients with hypoimmunogenic cells, and associated methods and compositions
|
|
AU2022283291A1
(en)
|
2021-05-27 |
2023-11-02 |
Sana Biotechnology, Inc. |
Hypoimmunogenic cells comprising engineered hla-e or hla-g
|
|
AU2022309875A1
(en)
|
2021-07-14 |
2024-01-25 |
Sana Biotechnology, Inc. |
Altered expression of y chromosome-linked antigens in hypoimmunogenic cells
|
|
AU2022326565A1
(en)
|
2021-08-11 |
2024-02-08 |
Sana Biotechnology, Inc. |
Genetically modified cells for allogeneic cell therapy
|
|
WO2023019227A1
(en)
|
2021-08-11 |
2023-02-16 |
Sana Biotechnology, Inc. |
Genetically modified cells for allogeneic cell therapy to reduce complement-mediated inflammatory reactions
|
|
AU2022325955A1
(en)
|
2021-08-11 |
2024-02-08 |
Sana Biotechnology, Inc. |
Genetically modified cells for allogeneic cell therapy to reduce instant blood mediated inflammatory reactions
|
|
KR20240053673A
(ko)
|
2021-08-11 |
2024-04-24 |
사나 바이오테크놀로지, 인크. |
저면역원성 세포 내 유전자 발현을 변경하기 위한 유도성 시스템
|
|
WO2023183313A1
(en)
|
2022-03-22 |
2023-09-28 |
Sana Biotechnology, Inc. |
Engineering cells with a transgene in b2m or ciita locus and associated compositions and methods
|
